Welcome to CSNpharm! For Research Use Only!
Home Compound Arrays Promotion +1-708-781-1677 sales@csnpharm.com    

Myosin light-chain kinase also known as MYLK or MLCK is a serine/threonine-specific protein kinase that phosphorylates a specific myosin light chain, namely, the regulatory light chain of myosin II.


Cat. No. Product Name CAS No. Information
CSN12294 ML-7 HCl   110448-33-4 ML-7 HCl is a multiple-target inhibitor of MLCK with Ki value of 300 nM PKA with 21M and PKC of 42 M
CSN23710 ML-9 105637-50-1 ML 9 a is myosin light chain kinase (MLCK) inhibitor. ML-9 enhances the anticancer activity of docetaxel, suggesting its potential application as an adjuvant to existing anticancer chemotherapy. The complex effect of ML-9 on autophagy and indentified ML-9 as an attractive tool for targeting autophagy in cancer therapy through dual inhibition of both the Akt pathway and the autophagy.
<< PREV 1 NEXT >>